The U.S. Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market.
US high court to decide on allowing Vioxx suitsCourtesy Newsvine - business Tue, 05/26/2009 - 08:09
The U.S. Supreme Court will decide whether shareholders can sue Merck & Co. over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market. Related itemsCourt to consider whether to allow Vioxx lawsuits
Merck loses $473M tax appeal in Schering case
Selected first-quarter drug sales for Merck & Co.
Samsung SCX-4200 3-in-1 True Multifunction Printer
BlueAnt UNOTPBAX53 X5 Bluetooth Stereo Headphone...
|
Post new comment